Holen Sie sich die Stockscreener-App
0.7502
3.29%
-0.0255
Handel nachbörslich:
.75
-0.0002
-0.03%
Schlusskurs vom Vortag:
$0.7757
Offen:
$0.78
24-Stunden-Volumen:
63,333
Relative Volume:
0.68
Marktkapitalisierung:
$3.26M
Einnahmen:
$79,300
Nettoeinkommen (Verlust:
$-6.92M
KGV:
-0.0395
EPS:
-18.9818
Netto-Cashflow:
$-5.34M
1W Leistung:
-4.46%
1M Leistung:
-16.64%
6M Leistung:
-60.10%
1J Leistung:
-42.29%
1-Tages-Spanne:
$0.7222
$0.78
1-Wochen-Bereich:
$0.7222
$0.81
52-Wochen-Spanne:
$0.7222
$8.9999
Virax Biolabs Group Ltd Stock (VRAX) Company Profile
Firmenname
Virax Biolabs Group Ltd
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie VRAX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VRAX
Virax Biolabs Group Ltd
|
0.7502 | 3.37M | 79,300 | -6.92M | -5.34M | -18.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Virax Biolabs Group Ltd Stock (VRAX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Eingeleitet | H.C. Wainwright | Buy |
Virax Biolabs Group Ltd Aktie (VRAX) Neueste Nachrichten
Virax Biolabs Group Limited Attempts Reversal From Key Support2025 Fundamental Recap & Long-Term Growth Plans - beatles.ru
Market reaction to Virax Biolabs Group Limited’s recent newsStop Loss & Short-Term High Return Strategies - Newser
Analyzing drawdowns of Virax Biolabs Group Limited with statistical toolsJuly 2025 News Drivers & Real-Time Buy Signal Alerts - Newser
Is Virax Biolabs Group Limited stock reversal real or fakeFree Entry Alert Based on Volume Spikes - Newser
Applying big data sentiment scoring on Virax Biolabs Group LimitedFree Trend Following Strategy With Stop Loss - Newser
Virax Biolabs Group Limited stock trend forecastPrice Spike Prediction for Active Traders - Newser
Can momentum traders help lift Virax Biolabs Group LimitedTrade Safety Report with Pattern Insights - Newser
Using AI based signals to follow Virax Biolabs Group LimitedRapid Trade Forecast Based on Indicators - Newser
What makes Virax Biolabs Group Limited stock price move sharplyFree Secure Return Focused Investment Plan - Newser
Visualizing Virax Biolabs Group Limited stock with heatmapsFree Real Time Stock Movement Analysis - Newser
Does Virax Biolabs Group Limited stock perform well during market downturnsDiscover high-growth stocks for your portfolio - Jammu Links News
How does Virax Biolabs Group Limited generate profit in a changing economyCapitalize on emerging industry trends - Jammu Links News
What catalysts could drive Virax Biolabs Group Limited stock higher in 2025Achieve consistent profits with proven methods - Jammu Links News
Is it the right time to buy Virax Biolabs Group Limited stockBuild a diversified portfolio for steady growth - Jammu Links News
Virax Biolabs Appoints Dr. Iain Miller as New Independent Director - TipRanks
Published on: 2025-07-30 13:38:22 - beatles.ru
How to build a custom watchlist for Virax Biolabs Group LimitedHigh Yield Signals with Entry Timing - Newser
Virax Biolabs Group Limited’s volatility index tracking explainedFree Risk Controlled Picks With Real Returns - Newser
Virax Biolabs appoints Iain Miller as independent director - Investing.com Australia
Former GE Healthcare Executive Joins Virax Board to Accelerate Diagnostic Platform Expansion - Stock Titan
Using economic indicators to assess Virax Biolabs Group Limited potentialFree Real Profit Trade Plan Suggestions - Newser
Virax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial Strategy - Yahoo Finance
Is Virax Biolabs Group Limited stock overvalued or undervaluedFree Daily Trading Room Entry - jammulinksnews.com
What are the latest earnings results for Virax Biolabs Group LimitedBuild wealth with steady, reliable stocks - Jammu Links News
Why is Virax Biolabs Group Limited stock attracting strong analyst attentionGet real-time alerts on top stocks - Jammu Links News
Technical Analysis: TGB Banquets and Hotels Limited (532845)Consistent wealth multiplication - Autocar Professional
Virax Biolabs Group Limited Stock Analysis and ForecastFree Wealth Planning Blueprint - jammulinksnews.com
Technical Analysis: SPEL Semiconductor Limited (517166)Extraordinary performance - Autocar Professional
Is Virax Biolabs Group Limited a good long term investmentSuperior trading gains - jammulinksnews.com
What analysts say about Allient Inc. stockGame-changing returns - jammulinksnews.com
What analysts say about Virax Biolabs Group Limited stockExceptional market performance - Jammu Links News
AI for Trademark Infringement DetectionAlpha Stock Ideas - Newser
ICICI Prudential AMC Ltd (542631) Announces Strategic ShiftExceptional earning trajectories - jammulinksnews.com
What drives Virax Biolabs Group Limited stock priceAccelerated wealth building - Autocar Professional
Virax Biolabs receives Nasdaq minimum bid price deficiency notice By Investing.com - Investing.com India
Virax Biolabs receives Nasdaq minimum bid price deficiency notice - Investing.com Australia
Virax Biolabs Gets NASDAQ Deficiency Notice: What the 180-Day Compliance Timeline Means for Investors - Stock Titan
How Virax Biolabs Group Limited stock performs during market volatilityFree Step-by-Step Investment Guide - Newser
Why ATCH stock attracts strong analyst attentionFree Consultation - Newser
Why Virax Biolabs Group Limited stock attracts strong analyst attentionFree Stock Portfolio Optimization - Newser
Virax Biolabs Group (NASDAQ:VRAX) Stock Price Up 0.7% – Time to Buy? - Defense World
Virax Biolabs Group Full Year 2025 Earnings: Misses Expectations - simplywall.st
Virax Biolabs Announces CFO Resignation and Transition - TipRanks
FibroBiologics names new CFO after going public last year - The Business Journals
Kaival Brands Innovations Group (NASDAQ:KAVL) Trading Down 1.2% – Time to Sell? - Defense World
Virax Biolabs Group (NASDAQ:VRAX) Stock Price Up 2% – Here’s What Happened - Defense World
Virax Biolabs Group (NASDAQ:VRAX) Trading Up 6.9% – Here’s What Happened - Defense World
Finanzdaten der Virax Biolabs Group Ltd-Aktie (VRAX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):